Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Working Group Meeting, January 24-25, 2005 Agenda

This website is archived for historical purposes and is no longer being maintained or updated.


Westin Peachtree Plaza Hotel – Atlanta, GA

View Meeting Summary | View Meeting Participants

 

Monday, January 24
Time Activity Speaker
7:30 – 8:00 Continental Breakfast  
8:00 – 8:15 Welcome and Introductions Diane Wagener
8:15 – 8:30 Public Health Assessment of Genomic Applications Muin Khoury
8:30– 8:45 Meeting Goals and Objectives Diane Wagener
8:45 – 9:00 Comments on current approaches to evaluation and future potential – Tab 3 Linda Bradley
9:00 – 9:30 Components of Evaluation : Describing the Disorder, Test, and Setting – Tab 4 James Haddow
9:30 – 10:30 Components of Evaluation : Analytic Validity (AV) – Tab 5 Glenn Palomaki
10:30 – 10:45 Break  
10:45 – 12:15

Components of Evaluation : Clinical Validity (CV)- Tab 6

 Ingeborg Blancquaert
12:15 – 12:30

Break and Buffet – Return for Working Lunch

  
12:30 – 2:00 Components of Evaluation : Clinical Utility – Tab 7 Steve Teutsch  
2:00 – 3:00 Components of Evaluation : Ethical, Legal and Social Implications – Tab 8 Wylie Burke
2:00 – 3:30 Methodology – Discussion of issues identified in the morning session Al Berg
3:15 – 3:30 Break  
3:30 – 4:00

Review and Updating of Reports – Tab 9

 Peter Briss
4:00 – 5:00

Day 1 Facilitated Discussion (All attendees)

  • Development of themes/conclusions from the sessions
  • Questions and comments
 Diane Wagener

 

 

Tuesday, January 25
Time Activity Speaker
8:00 – 8:30 Continental Breakfast  

8:30 – 10:00

Products and Dissemination of Information – Tab 10

 Gurvaneet Randhava
10:00 – 10:15 Break  
10:15 – 12:15

Facilitated Discussion (All attendees)

  • Review of themes and conclusions
  • Areas of agreement
  • Compatibility with current standards of practice?
  • How can we facilitate/support the development of research agendas based on identified gaps in evidence?
  • Is there any consensus on 5-10 topics that would be high priority for review?
 Al Berg
12:15 – 12:30

Summary of Meeting/Closing Remarks

  • Elicit suggestions for other professionals to involve as advisors, content experts, or peer-reviewers
  • Request for information about relevant studies currently being conducted (PI, contact information, and project description)
  • Closing thoughts and solicitation of opinion from participants on the desired outcome from this meeting
  • Expression of thanks from RTI and CDC for helpful insights and participation
 Diane Wagener
Muin Khoury
Linda Bradley
TOP